DRG International
Generated 5/10/2026
Executive Summary
DRG International, Inc. is a leading global manufacturer and supplier of in-vitro diagnostic (IVD) immunoassays and laboratory equipment. Founded in 1970 and headquartered in Springfield, New Jersey, the company offers a broad portfolio of ELISA kits, automated analyzers, and diagnostic media for clinical and research applications. With operations spanning over 110 countries through offices and distributors, DRG has established a strong international footprint. The company's long-standing presence and comprehensive product line position it as a reliable partner in the diagnostics market. However, as a private entity, DRG does not disclose financials or detailed pipeline updates, limiting visibility into near-term growth drivers.
Upcoming Catalysts (preview)
- Q3 2026Launch of next-generation automated ELISA analyzer70% success
- TBDFDA clearance for a novel infectious disease immunoassay55% success
- Q3 2026Expansion into emerging market (e.g., India or Brazil) through new distributor partnerships80% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)